# 7G BioVentures I, L.P. — Form D/A

7G BioVentures I, L.P. of Belmont, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-01. The offering totals $100.0M, of which $32.7M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2023-11-01
- Form: D/A
- Accession: 0001889714-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Amount sold: $32.7M
- Remaining: $67.3M
- Minimum investment: $100K
- Investors: 24
- Date of first sale: 2021-11-30
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-422776

## Issuer

- Name: 7G BioVentures I, L.P.
- CIK: 0001889714
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 1730 Belburn Drive, Belmont, CA, 94002
- Phone: 805-405-8658

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Wenkai Xiang | Executive Officer | Walpole, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-11-29](https://search.stillhousedata.com/formd/0001889714-21-000001) | D | $100.0M | — |

## More

- [CIK 1889714 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1889714&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001889714-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.